Cogent Biosciences, Inc. (COGT)
40.04
+0.87
(+2.22%)
USD |
NASDAQ |
Dec 11, 16:00
40.07
+0.03
(+0.07%)
After-Hours: 06:19
Cogent Biosciences Free Cash Flow: -246.73M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| ADMA Biologics, Inc. | 40.61M |
| Editas Medicine, Inc. | -180.70M |
| AnaptysBio, Inc. | -145.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -64.29M |
| Cash from Investing (Quarterly) | -155.05M |
| Cash from Financing (Quarterly) | 217.37M |
| Free Cash Flow Per Share (Quarterly) | -0.4678 |
| Free Cash Flow to Equity (Quarterly) | -64.25M |
| Free Cash Flow to Firm (Quarterly) | -62.89M |
| Free Cash Flow Yield | -5.18% |